{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:56:52Z","timestamp":1792634212916,"version":"4.5.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>A sensitive and rapid ultra-performance liquid chromatography\u2013tandem mass spectrometry (UPLC-MS\/MS) method was hereby developed for the determination of seven components, namely, glycyrrhizic acid, glycyrrhetinic acid, dehydrotumulosic acid, isoliquiritin, liquiritin, atractylenolide III, and cinnamic acid, in the plasma of rats after the oral administration of Ling-Gui-Zhu-Gan decoction (LGZGD). Besides, this very method was methodologically validated for specificity, linearity, inter-day and intra-day precision, accuracy, matrix effect, extraction recovery, and stability. It was also successfully used for the first time to compare the pharmacokinetic characteristics of the seven components after oral administration of LGZGD to normal rats and non-alcoholic fatty liver disease (NAFLD) rats. The results indicated significant differences between the pharmacokinetic characteristics of normal and NAFLD rats. To further reveal the different pharmacokinetic behaviors, the expressions of enzymes and transporters in the liver of normal and NAFLD rats were detected using UPLC-MS\/MS. In the NAFLD rats, UDP-glucuronosyltransferase 1-1 (UGT1A1) and nine transporters were significantly inhibited and a positive correlation was observed between them and the AUC of the major components. The present results indicate that the pharmacokinetic differences between the normal and NAFLD rats might be attributed to the significant lower expression levels of both the metabolic enzyme UGT1A1 and nine transporter proteins in the NAFLD rats than in the normal rats. Meanwhile, UGT1A1 and the nine transporter proteins might be used as potential biomarkers to assess the ameliorative effect of LGZGD on NAFLD, which could provide useful information to guide the clinical application of LGZGD.<\/jats:p>","DOI":"10.3389\/fphar.2023.1174742","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:11:56Z","timestamp":1683173516000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of pharmacokinetic profiles of seven major bioactive components in normal and non-alcoholic fatty liver disease (NAFLD) rats after oral administration of Ling-Gui-Zhu-Gan decoction by UPLC-MS\/MS"],"prefix":"10.3389","volume":"14","author":[{"given":"Wenlong","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1021\/np0780001","article-title":"Triterpene acids fromPoria cocos and their anti-tumor-promoting effects","volume":"70","author":"Akihisa","year":"2007","journal-title":"J. Nat. Prod."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s0254-6272(11)60038-1","article-title":"Effects of the modified linggui zhugan decoction (see text) combined with short-term very low calorie diets on glycemic control in newly diagnosed type 2 diabetics","volume":"31","author":"Chen","year":"2011","journal-title":"J. Tradit. Chin. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13318-018-0499-1","article-title":"Influence of orally administered borneol on the expression of hepatic transporters in rats","volume":"44","author":"Chen","year":"2019","journal-title":"Eur. J. Drug Metab. Ph."},{"key":"B5","doi-asserted-by":"publisher","first-page":"172421","DOI":"10.1016\/j.ejphar.2019.172421","article-title":"The involvement of DAMPs-mediated inflammation in cyclophosphamide-induced liver injury and the protection of liquiritigenin and liquiritin","volume":"856","author":"Chen","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B6","volume-title":"Pharmacopoeia of the people's Republic of China","year":"2020"},{"key":"B7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jchromb.2007.12.028","article-title":"Simultaneous determination of berberine, palmatine and jatrorrhizine by liquid chromatography\u2013tandem mass spectrometry in rat plasma and its application in a pharmacokinetic study after oral administration of coptis\u2013evodia herb couple","volume":"863","author":"Deng","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B9","first-page":"25","article-title":"The therapeutic effects of ling gui Zhu Gan tang mixture in 50 psychotic patients with obesity induced by the psychoactive drugs","volume":"25","author":"Ding","year":"2005","journal-title":"J. Tradit. Chin. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2009.04.002","article-title":"Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats","volume":"613","author":"Fisher","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"118986","DOI":"10.1016\/j.lfs.2020.118986","article-title":"Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease","volume":"267","author":"Gu","year":"2021","journal-title":"Life Sci."},{"key":"B12","volume-title":"History evolution on the classical famous prescription of Linggui Zhugan Decoction","author":"Gu","year":"2020"},{"key":"B13","first-page":"145","article-title":"History evolution on the classical famous prescription of Linggui Zhugan Decoction","volume":"17","author":"Gu","year":"2020","journal-title":"Chin. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"6178358","DOI":"10.1155\/2017\/6178358","article-title":"Yinchen linggui zhugan decoction ameliorates nonalcoholic fatty liver disease in rats by regulating the Nrf2\/ARE signaling pathway","volume":"2017","author":"Guo","year":"2017","journal-title":"Evid.-based Compl. Alt."},{"key":"B15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.talanta.2018.08.020","article-title":"LC-ESI-MS\/MS method for simultaneous determination of eleven bioactive compounds in rat plasma after oral administration of Ling-Gui-Zhu-Gan Decoction and its application to a pharmacokinetics study","volume":"190","author":"Ji","year":"2018","journal-title":"Talanta"},{"key":"B16","first-page":"909","article-title":"Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese zucker and sprague-dawley rats: Implications of decreased glucuronidation in obese zucker rats","volume":"32","author":"Kim","year":"2004","journal-title":"Drug metabolism Dispos. Biol. fate Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jnutbio.2009.11.009","article-title":"Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease","volume":"22","author":"Kirpich","year":"2011","journal-title":"J. Nutr. Biochem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.mam.2012.10.010","article-title":"The SLC22 family with transporters of organic cations, anions and zwitterions","volume":"34","author":"Koepsell","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1124\/pr.113.007518","article-title":"Transporters and drug-drug interactions: Important determinants of drug disposition and effects","volume":"65","author":"K\u00f6nig","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1515\/dmpt-2016-0008","article-title":"Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease","volume":"31","author":"Kulkarni","year":"2016","journal-title":"Drug Metabolism Personalized Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11655-020-3268-3","article-title":"Intestinal microecology: An important target for Chinese medicine treatment of non-alcoholic fatty liver disease","volume":"26","author":"Li","year":"2020","journal-title":"Chin. J. Integr. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02648725.2023.2199541","article-title":"Clinical effect of 'Fast-track Management' guided by ERAS concept under the multi-disciplinary cooperation mode of femoral intertrochanteric fracture in the elderly","author":"Li","year":"2023","journal-title":"Chin. Tradit. Pat. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1124\/dmd.110.036806","article-title":"Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis","volume":"39","author":"Li","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-mediated AMPK pathway","volume":"18","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1124\/dmd.107.015107","article-title":"Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease","volume":"35","author":"Lickteig","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.11817\/j.issn.1672-7347.2020.190359","article-title":"Progress in the study on innate immunity and non-alcohol fatty liver disease","volume":"45","author":"Lou","year":"2020","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"key":"B28","doi-asserted-by":"publisher","first-page":"655332","DOI":"10.3389\/fphar.2021.655332","article-title":"Comparative studies on multi-component pharmacokinetics of polygonum multiflorum thunb extract after oral administration in different rat models","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2217\/pgs.11.44","article-title":"Transporter-mediated drug\u2013drug interactions","volume":"12","author":"M\u00fcller","year":"2011","journal-title":"Pharmacogenomics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/s0168-8278(00)80120-8","article-title":"Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases","volume":"33","author":"Niemela","year":"2000","journal-title":"J. Hepatol."},{"key":"B31","first-page":"105","article-title":"Organic cation transporters (OCTs, MATEs)","volume-title":"and","author":"Nies","year":"2011"},{"key":"B32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/antiox11050961","article-title":"18\u03b2-Glycyrrhetinic acid protects against cholestatic liver injury in bile duct-ligated rats","volume":"11","author":"Pan","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"100346","DOI":"10.1016\/j.jhepr.2021.100346","article-title":"New targets for NAFLD","volume":"3","author":"Parlati","year":"2021","journal-title":"JHEP Rep. innovation hepatology"},{"key":"B34","first-page":"733","article-title":"Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease","volume":"91","author":"Prompila","year":"2008","journal-title":"J. Med. Assoc. Thail."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e4521","DOI":"10.1002\/bmc.4521","article-title":"Comparative pharmacokinetics of nine major bioactive components in normal and ulcerative colitis rats after oral administration of Lizhong decoction extracts by UPLC\u2013TQ\u2013MS\/MS","volume":"33","author":"Shen","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/chromsci\/40.4.198","article-title":"An HPLC method for the determination and pharmacokinetic study of cinnamic acid in the plasma of rats having taken the traditional Chinese medicinal preparation Ling-Gui-Zhu-Gan decoction","volume":"40","author":"Song","year":"2002","journal-title":"J. Chromatogr. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1570-0232(02)00411-7","article-title":"High-performance liquid chromatographic method for the determination and pharmacokinetic study of dehydrotumulosic acid in the plasma of rats having taken the traditional Chinese medicinal preparation Ling-Gui-Zhu-Gan decoction","volume":"788","author":"Song","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","article-title":"Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"18","author":"Takahashi","year":"2012","journal-title":"World J. gastroentero."},{"key":"B39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1021\/np0103721","article-title":"Inhibition of tumor-promoting effects by poricoic acids G and H and other lanostane-type triterpenes and cytotoxic activity of poricoic acids A and G fromPoria cocos","volume":"65","author":"Ukiya","year":"2002","journal-title":"J. Nat. Prod."},{"key":"B40","doi-asserted-by":"publisher","first-page":"284847","DOI":"10.1155\/2012\/284847","article-title":"Control strategy on hypertension in Chinese medicine","volume":"2012","author":"Wang","year":"2012","journal-title":"Evid.-based Compl. Alt."},{"key":"B41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1124\/dmd.114.061580","article-title":"Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics","volume":"43","author":"Wang","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"B42","doi-asserted-by":"publisher","first-page":"121110","DOI":"10.1016\/j.lfs.2022.121110","article-title":"Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet","volume":"310","author":"Wang","year":"2022","journal-title":"Life Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"112397","DOI":"10.1016\/j.jep.2019.112397","article-title":"Integrative serum metabolomics and network analysis on mechanisms exploration of Ling-Gui-Zhu-Gan Decoction on doxorubicin-induced heart failure mice","volume":"250","author":"Wang","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"8860603","DOI":"10.1155\/2020\/8860603","article-title":"Ling-Gui-Zhu-Gan decoction protects H9c2 cells against H2O2-induced oxidative injury via regulation of the nrf2\/keap1\/HO-1 signaling pathway","volume":"2020","author":"Wang","year":"","journal-title":"Evid.-based Compl. Alt."},{"key":"B45","doi-asserted-by":"publisher","first-page":"9561613","DOI":"10.1155\/2021\/9561613","article-title":"Cinnamic acid ameliorates nonalcoholic fatty liver disease by suppressing hepatic lipogenesis and promoting fatty acid oxidation","volume":"2021","author":"Wu","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.fitote.2011.10.001","article-title":"Comparative pharmacokinetics of three triterpene acids in rat plasma after oral administration of Poria extract and its formulated herbal preparation: GuiZhi-FuLing capsule","volume":"83","author":"Xiao","year":"2012","journal-title":"Fitoterapia"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.3390\/molecules23102514","article-title":"UPLC-MS\/MS method for the determination of 14 compounds in rat plasma and its application in a pharmacokinetic study of orally administered xiaoyao powder","volume":"23","author":"Xu","year":"2018","journal-title":"Molecules"},{"key":"B48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jpba.2013.01.011","article-title":"Pharmacokinetic study of major bioactive components in rats after oral administration of extract of Ilex hainanensis by high-performance liquid chromatography\/electrospray ionization mass spectrometry","volume":"77","author":"Yang","year":"2013","journal-title":"J. Pharm. Biomed."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3736\/jcim20121008","article-title":"Comparative study on the effects of different therapeutic methods in preventing and treating nonalcoholic fatty liver in rats","volume":"10","author":"Yang","year":"2012","journal-title":"J. Chin. Integr. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fphar.2018.00510","article-title":"Yinchenhao decoction ameliorates alpha-naphthylisothiocyanate induced intrahepatic cholestasis in rats by regulating phase II metabolic enzymes and transporters","volume":"9","author":"Yi","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1089\/jmf.2016.0023","article-title":"A standardized composition from extracts of myristica fragrans, Astragalus membranaceus, and Poria cocos protects liver from acute ethanol insult","volume":"19","author":"Yimam","year":"2016","journal-title":"J. Med. Food"},{"key":"B52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: A systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.jchromb.2010.06.021","article-title":"Comparative pharmacokinetics of baicalin and wogonoside by liquid chromatography\u2013mass spectrometry after oral administration of Xiaochaihu Tang and Radix scutellariae extract to rats","volume":"878","author":"Zhu","year":"2010","journal-title":"J. Chromatogr. B"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1174742\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:12:09Z","timestamp":1683173529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1174742\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":54,"alternative-id":["10.3389\/fphar.2023.1174742"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1174742","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,4]]},"article-number":"1174742"}}